DRKS00009219已完成不适用
Biologica in patients with ulcerative colitis in Germany (BioColitis study) - BioColitis Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 885
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. ulcerative colitis patients (age at inclusion: 18-80 years ) with a new biologics therapy with Adalimumab, Infliximab, Golimumab or Vedolizumab.
- •2. ulcerative colitis patients (age at inclusion: 18-80 years ) with an early disease history (initial diagnosis <2 years).
排除标准
- •Age < 18 years >80 years
研究者
相似试验
招募中
1 期
Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampnesslcerative colitisITMCTR2000003426Guangdong Provincial Hospital of Chinese Medicine
招募中
不适用
Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remissioulcerative colitisJPRN-UMIN000043098Sapporo Medical University150
已完成
不适用
Faecal transplant for the treatment of active ulcerative colitisUlcerative colitisACTRN12613000236796Royal Adelaide Hospital70
进行中（未招募）
1 期
Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova (TSO)EUCTR2017-004772-65-DKParaTech A/S120
已完成
不适用
Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximabulcerative colitisJPRN-UMIN000020402IBD Relapse Prevention Team50